| 1 | 164662-46-8 | 替马沙星杂质190 | NA | C23H24FN3O3
| | |
| 2 | 2468199-06-4 | H3B-616 | H3B-616 | C23H24FN3O3
| | |
| 3 | 95374-52-0 | 普地哌隆 | Prideperone | C23H24FN3O3
| | |
| 4 | 1514888-56-2 | CS-2465 | S1p receptor agonist 1 | C23H24FN3O3
| | |
| 5 | 1775495-04-9 | 1-(2-ethoxybenzoyl)-4-{[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]methyl}piperidine | 1-(2-ethoxybenzoyl)-4-{[3-(4-fluorophenyl)-1,2,4-oxadiazol-5-yl]methyl}piperidine | C23H24FN3O3
| | |
| 6 | 114088-54-9 | 2,4(1H,3H)-Quinazolinedione, 3-[2-[4-(5-fluoro-2-methylbenzoyl)-1-piperidinyl]ethyl]- | 2,4(1H,3H)-Quinazolinedione, 3-[2-[4-(5-fluoro-2-methylbenzoyl)-1-piperidinyl]ethyl]- | C23H24FN3O3
| | |
| 7 | | N'-(3-fluorobenzylidene)-1-hexyl-4-hydroxy-2-oxo-1,2-dihydro-3-quinolinecarbohydrazide | N'-(3-fluorobenzylidene)-1-hexyl-4-hydroxy-2-oxo-1,2-dihydro-3-quinolinecarbohydrazide | C23H24FN3O3
| | |
| 8 | 728014-43-5 | 4-benzoyl-5-(4-fluorophenyl)-3-hydroxy-1-[2-(1-piperazinyl)ethyl]-1,5-dihydro-2H-pyrrol-2-one | 4-benzoyl-5-(4-fluorophenyl)-3-hydroxy-1-[2-(1-piperazinyl)ethyl]-1,5-dihydro-2H-pyrrol-2-one | C23H24FN3O3
| | |
| 9 | | N-(3-FLUOROPHENYL)-4-[(5-OXO-5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL)CARBONYL]-1,4-DIAZEPANE-1-CARBOXAMIDE | N-(3-FLUOROPHENYL)-4-[(5-OXO-5,6,7,8-TETRAHYDRONAPHTHALEN-2-YL)CARBONYL]-1,4-DIAZEPANE-1-CARBOXAMIDE | C23H24FN3O3
| | |
| 10 | 179420-14-5 | | 2H-Pyran-4-carboxamide, 4-[3-fluoro-5-[[4-(2-methyl-1H-imidazol-1-yl)phenyl]methoxy]phenyl]tetrahydro- | C23H24FN3O3
| | |
| 11 | 1326921-50-9 | 2-[2-(4-fluorophenyl)-5-(2-hydroxyethyl)-4-methyl-6-oxopyrimidin-1-yl]-N-methyl-N-(3-methylphenyl)acetamide | 2-[2-(4-fluorophenyl)-5-(2-hydroxyethyl)-4-methyl-6-oxopyrimidin-1-yl]-N-methyl-N-(3-methylphenyl)acetamide | C23H24FN3O3
| | |
| 12 | 2428642-40-2 | 4-[[(1'-BOC-1',2',3',6'-四氢-[2,4'-联吡啶]-6-基)氧基]甲基]-3-氟苯腈 | [2,4'-Bipyridine]-1'(2'H)-carboxylic acid, 6-[(4-cyano-2-fluorophenyl)methoxy]-3',6'-dihydro-, 1,1-dimethylethyl ester | C23H24FN3O3
| | |